The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
C-Reactive Protein in Atherothrombosis and Angiogenesis
Open accessAbstract
C-reactive protein (CRP) is a short pentraxin mainly found as a pentamer in the circulation, or as non-soluble monomers CRP (mCRP) in tissues, exerting different functions. This review is focused on discussing the role of CRP in cardiovascular disease, including recent advances on the implication of CRP and its forms specifically on the pathogenesis of atherothrombosis and angiogenesis. Besides its role in the humoral innate immune response, CRP contributes to cardiovascular disease progression by recognizing and binding multiple intrinsic ligands. mCRP is not present in the healthy vessel wall but it becomes detectable in the early stages of atherogenesis and accumulates during the progression of atherosclerosis. CRP inhibits endothelial nitric oxide production and contributes to plaque instability by increasing endothelial cell adhesion molecules expression, by promoting monocyte recruitment into the atheromatous plaque and by enzymatically binding to modified low-density lipoprotein. CRP also contributes to thrombosis, but depending on its form it elicits different actions. Pentameric CRP has no involvement in thrombogenesis, whereas mCRP induces platelet activation and thrombus growth. In addition, mCRP has apparently contradictory pro-angiogenic and anti-angiogenic effects determining tissue remodeling in the atherosclerotic plaque and in infarcted tissues. Overall, CRP contributes to cardiovascular disease by several mechanisms that deserve an in-depth analysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921 · Cited by 3,503
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953
Production of C-reactive protein and risk of coronary events in stable and unstable angina
Haverkate, E., Thompson, S. G., Pyke, S. D., Gallimore, J. R., & Group, M. B. P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07591-5 · Cited by 1,500
C-reactive protein, fibrinogen, and cardiovascular disease prediction
The Emerging Risk Factors Collaboration (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1107477 · Cited by 1,150
Verma, S., Wang, C.-H., Li, S.-H., Dumont, A. S., Fedak, P. W. M., Badiwala, M. V., Dhillon, B., Weisel, R. D., Li, R.-K., Mickle, D. A. G., et al. (2002) · Circulation · doi:10.1161/01.cir.0000029802.88087.5e · Cited by 1,054
Ridker, P. M., Glynn, R. J., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.97.20.2007 · Cited by 1,013
Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular Causes
Zethelius, B., Berglund, L., Sundström, J., Ingelsson, E., Basu, S., Larsson, A., Venge, P., & Ärnlöv, J. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707064 · Cited by 889
C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor
Cermak, J., Key, N., Bach, R., Balla, J., Jacob, H., & Vercellotti, G. (1993) · Blood · doi:10.1182/blood.v82.2.513.513 · Cited by 839
The physiological structure of human C-reactive protein and its complex with phosphocholine
Thompson, D., Pepys, M. B., & Wood, S. P. (1999) · Structure · doi:10.1016/s0969-2126(99)80023-9 · Cited by 818 · cited 1×
“The native circulating form of CRP is pentameric (pCRP), that is a disc of five identical subunits noncovalently bounded around a central pore (4).”
BackgroundVigushin, D. M., Pepys, M. B., & Hawkins, P. N. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116336 · Cited by 636
Verma, S., Kuliszewski, M. A., Li, S.-H., Szmitko, P. E., Zucco, L., Wang, C.-H., Badiwala, M. V., Mickle, D. A. G., Weisel, R. D., Fedak, P. W. M., et al. (2004) · Circulation · doi:10.1161/01.cir.0000127577.63323.24 · Cited by 525
Chang, M.-K., Binder, C. J., Torzewski, M., & Witztum, J. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192399699 · Cited by 521
Dehghan, A., Dupuis, J., Barbalic, M., Bis, J. C., Eiriksdottir, G., Lu, C., Pellikka, N., Wallaschofski, H., Kettunen, J., Henneman, P., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.948570 · Cited by 511
High-Sensitivity C-Reactive Protein and Cardiovascular Disease
Yousuf, O., Mohanty, B. D., Martin, S. S., Joshi, P. H., Blaha, M. J., Nasir, K., Blumenthal, R. S., & Budoff, M. J. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.016 · Cited by 494
Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis
Li, Y., Zhong, X., Cheng, G., Zhao, C., Zhang, L., Hong, Y., Wan, Q., He, R., & Wang, Z. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.02.003 · Cited by 418
Scola, L., Di Maggio, F. M., Vaccarino, L., Bova, M., Forte, G. I., Pisano, C., Candore, G., Colonna-Romano, G., Lio, D., Ruvolo, G., et al. (2014) · Mediators of Inflammation · doi:10.1155/2014/165758 · Cited by 359
Bhakdi, S., Torzewski, M., Klouche, M., & Hemmes, M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.10.2348 · Cited by 326
Koenig, W. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.07.113 · Cited by 315
Calabro, P., Chang, D. W., Willerson, J. T., & Yeh, E. T. H. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.06.017 · Cited by 308
Eisenhardt, S. U., Habersberger, J., Murphy, A., Chen, Y.-C., Woollard, K. J., Bassler, N., Qian, H., von zur Muhlen, C., Hagemeyer, C. E., Ahrens, I., et al. (2009) · Circulation Research · doi:10.1161/circresaha.108.190611 · Cited by 272
Murayama, T., Tepper, O. M., Silver, M., Ma, H., Losordo, D. W., Isner, J. M., Asahara, T., & Kalka, C. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(02)00867-6 · Cited by 268
Mueller, C., Buettner, H. J., Hodgson, J. M., Marsch, S., Perruchoud, A. P., Roskamm, H., & Neumann, F.-J. (2002) · Circulation · doi:10.1161/01.cir.0000012625.02748.62 · Cited by 249
Activation of Inflammation and Coagulation After Infusion of C-Reactive Protein in Humans
Bisoendial, R. J., Kastelein, J. J. P., Levels, J. H. M., Zwaginga, J. J., van den Bogaard, B., Reitsma, P. H., Meijers, J. C. M., Hartman, D., Levi, M., & Stroes, E. S. G. (2005) · Circulation Research · doi:10.1161/01.res.0000163015.67711.ab · Cited by 234
Vascular smooth muscle cell activation by C-reactive protein
HATTORI, Y., MATSUMURA, M., & KASAI, K. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00855-6 · Cited by 217
Thiele, J. R., Habersberger, J., Braig, D., Schmidt, Y., Goerendt, K., Maurer, V., Bannasch, H., Scheichl, A., Woollard, K. J., von Dobschütz, E., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.007124 · Cited by 214
Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction
Vilahur, G., Juan-Babot, O., Peña, E., Oñate, B., Casaní, L., & Badimon, L. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.12.021 · Cited by 209
Self-citationTransitional changes in the CRP structure lead to the exposure of proinflammatory binding sites
Braig, D., Nero, T. L., Koch, H.-G., Kaiser, B., Wang, X., Thiele, J. R., Morton, C. J., Zeller, J., Kiefer, J., Potempa, L. A., et al. (2017) · Nature Communications · doi:10.1038/ncomms14188 · Cited by 205
Devaraj, S., Du Clos, T. W., & Jialal, I. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000168573.10844.ae · Cited by 177
Orn, S., Manhenke, C., Ueland, T., Damas, J. K., Mollnes, T. E., Edvardsen, T., Aukrust, P., & Dickstein, K. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp070 · Cited by 170
Devaraj, S., & Jialal, I. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.225508 · Cited by 158
Grundy, S. M., Bazzarre, T. L., Cleeman, J. I., D’Agostino, R. B., Hill, M. N., Miller, N. H., Kannel, W. B., Krauss, R. M., Krumholz, H. M., Lauer, R. M., et al. (2000) · Circulation · doi:10.1161/01.cir.101.1.e3 · Cited by 157
Potempa, L. A., Siegel, J. N., Fedel, B. A., Potempa, R. T., & Gewurz, H. (1987) · Molecular Immunology · doi:10.1016/0161-5890(87)90028-9 · Cited by 151
The vasa vasorum in diseased and nondiseased arteries
Mulligan‐Kehoe, M. J. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00884.2009 · Cited by 150
Khreiss, T., József, L., Potempa, L. A., & Filep, J. G. (2005) · Circulation Research · doi:10.1161/01.res.0000183881.11739.cb · Cited by 141
Complement C6 Deficiency Protects Against Diet-Induced Atherosclerosis in Rabbits
Schmiedt, W., Kinscherf, R., Deigner, H.-P., Kamencic, H., Nauen, O., Kilo, J., Oelert, H., Metz, J., & Bhakdi, S. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.11.1790 · Cited by 140
Habersberger, J., Strang, F., Scheichl, A., Htun, N., Bassler, N., Merivirta, R., Diehl, P., Krippner, G. Y., Meikle, P. J., Eisenhardt, S. U., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs237 · Cited by 135
Pentraxins in the activation and regulation of innate immunity
Daigo, K., Inforzato, A., Barajon, I., Garlanda, C., Bottazzi, B., Meri, S., & Mantovani, A. (2016) · Immunological Reviews · doi:10.1111/imr.12476 · Cited by 131
Studies on the interactions between C‐reactive protein and complement proteins
Bı́ró, A., Rovó, Z., Papp, D., Cervenak, L., Varga, L. Á., Füst, G., Thielens, N. M., Arlaud, G. J., & Prohászka, Z. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02535.x · Cited by 125
C-Reactive Protein Isoforms Differ in Their Effects on Thrombus Growth
Molins, B., Peña, E., Vilahur, G., Mendieta, C., SLEVIN, M. A., & Badimón, L. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.174359 · Cited by 116
Self-citationSlevin, M., Matou, S., Zeinolabediny, Y., Corpas, R., Weston, R., Liu, D., Boras, E., Di Napoli, M., Petcu, E., Sarroca, S., et al. (2015) · Scientific Reports · doi:10.1038/srep13281 · Cited by 115
Self-citationChen, J., Gu, Z.-J., Wu, M., Yang, Y., Zhang, J., Ou, J., Zuo, Z., Wang, J., & Chen, Y. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0377-1 · Cited by 114
Possible Protective Role for C-Reactive Protein in Atherogenesis
Bhakdi, S., Torzewski, M., Paprotka, K., Schmitt, S., Barsoom, H., Suriyaphol, P., Han, S., Lackner, K. J., & Husmann, M. (2004) · Circulation · doi:10.1161/01.cir.0000124228.08972.26 · Cited by 113
Boras, E. A., SLEVIN, M. A., Alexander, M. Y., Aljohi, A. O., Gilmore, W., Ashworth, J., Krupiński, J., Potempa, L. A., Abdulkareem, I. A., El‐Obeid, A., et al. (2014) · Cytokine · doi:10.1016/j.cyto.2014.05.027 · Cited by 101
Self-citationZouki, C., Haas, B., Chan, J. S. D., Potempa, L. A., & Filep, J. G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.5355 · Cited by 101
SLEVIN, M. A., Matou‐Nasri, S., Turu, M. M., Luque, A., Rovira, N., Badimón, L., Boluda, S., Potempa, L. A., Sanfeliu, C., de Vera, N., et al. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00256.x · Cited by 94
Self-citationComplement factor H binds to denatured rather than to native pentameric C-reactive protein
Hakobyan, S., Harris, C. L., van den Berg, C. W., Fernandez-Alonso, M. C., de Jorge, E. G., de Cordoba, S. R., Rivas, G., Mangione, P., Pepys, M. B., & Morgan, B. P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803648200 · Cited by 90 · cited 1×
“org March 2018 | Volume 9 | Article 430 activating the complement cascade (8), in angiogenesis (9) and in thrombosis (10), whereas pCRP is mostly released to the circulation after an inflammatory stimuli (1).”
BackgroundStumpf, C., Sheriff, A., Zimmermann, S., Schaefauer, L., Schlundt, C., Raaz, D., Garlichs, C. D., & Achenbach, S. S. (2017) · Archives of Medical Science · doi:10.5114/aoms.2017.69327 · Cited by 83
C-Reactive Protein and Coronary Heart Disease: All Said—Is Not It?
Strang, F., & Schunkert, H. (2014) · Mediators of Inflammation · doi:10.1155/2014/757123 · Cited by 81
Turu, M. M., SLEVIN, M. A., Matou, S., West, D. C., Rodríguez, C., Luque, A., Grau-Olivares, M., Badimón, L., Martínez‐González, J., & Krupiński, J. (2008) · BMC Cell Biology · doi:10.1186/1471-2121-9-47 · Cited by 75
Self-citationBiological actions of pentraxins
Vilahur, G., & Badimón, L. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.05.001 · Cited by 74
Self-citationKawanami, D., Maemura, K., Takeda, N., Harada, T., Nojiri, T., Saito, T., Manabe, I., Imai, Y., & Nagai, R. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.01.057 · Cited by 73
Cimmino, G., Ragni, M., Cirillo, P. L., Petrillo, G., Loffredo, F. S., Chiariello, M., Gresele, P., Falcinelli, E., & Golino, P. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.10.040 · Cited by 65
Cheng, J. M., Oemrawsingh, R. M., García‐García, H. M., Akkerhuis, K. M., Kardys, I., de Boer, S. P. M., Langstraat, J. S., Regar, E. S., van Geuns, R., Serruys, P. W. J. C., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.08.013 · Cited by 64
Guan, H., Wang, P., Hui, R., Edin, M. L., Zeldin, D. C., & Wang, D. W. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.115857 · Cited by 54
Li, H., Wang, J., Wu, Y., Zhang, L., Liu, Z.-P., Filep, J. G., Potempa, L. A., Wu, Y., & Ji, S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.555318 · Cited by 52
Vilahur, G., Vera, R. H., Molins, B., Casaní, L., Durán, X., Padró, T., & Badimón, L. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03244.x · Cited by 48
Self-citationSingh, S. K., Suresh, M. V., Prayther, D., Moorman, J. P., Rusiñol, A. E., & Agrawal, A. C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.4316 · Cited by 48
Inhibition of Endothelial Nitric Oxide Synthase by C-Reactive Protein: Clinical Relevance
Jialal, I., Verma, S., & Devaraj, S. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.119206 · Cited by 47
Doronzo, G., Russo, I., Mattiello, L., Trovati, M., & Anfossi, G. (2005) · Journal of Laboratory and Clinical Medicine · doi:10.1016/j.lab.2005.07.010 · Cited by 47
Bello, G., Cailotto, F., Hanriot, D., Kolopp‐Sarda, M., Latger‐Cannard, V., Hess, K., Zannad, F. M., Longrois, D., & Ropars, A. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.12.046 · Cited by 45
de la Torre, R., Peña, E., Vilahur, G., SLEVIN, M. A., & Badimón, L. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12415 · Cited by 43
Self-citationFunctional Transformation of C-reactive Protein by Hydrogen Peroxide
Singh, S. K., Thirumalai, A., Pathak, A., Ngwa, D. N., & Agrawal, A. C. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.773176 · Cited by 33
Diet microparticles and atherothrombosis
Badimón, L. (2017) · Frontiers in bioscience · doi:10.2741/4598 · Cited by 20
C‐reactive protein inhibits in vitro oxidation of low‐density lipoprotein
Rufail, M. L., Ramage, S., & van Antwerpen, R. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.08.045 · Cited by 18
Cited by
Research Progress on the Relationship between Atherosclerosis and Inflammation
Zhu, Y., Xian, X., Wang, Z., Bi, Y., Chen, Q., Han, X., Tang, D., & Chen, R. (2018) · Biomolecules · doi:10.3390/biom8030080 · Cited by 872
Mechanisms underlying the association between periodontitis and atherosclerotic disease
Schenkein, H. A., Papapanou, P. N., Genco, R., & Sanz, M. (2020) · Periodontology 2000 · doi:10.1111/prd.12304 · Cited by 440
C-reactive protein and implications in rheumatoid arthritis and associated comorbidities
Pope, J. E., & Choy, E. H. (2021) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2020.11.005 · Cited by 320
Abad-Jiménez, Z., López-Domènech, S., Gómez-Abril, S. Á., Periañez-Gómez, D., de Marañón, A. M., Bañuls, C., Morillas, C., Víctor, V. M., & Rocha, M. (2020) · Antioxidants · doi:10.3390/antiox9080734 · Cited by 17
Metadata
- Authors
- Badimon, L., Peña, E., Arderiu, G., Padró, T., Slevin, M., Vilahur, G., & Chiva-Blanch, G.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2018-03-02
- Volume
- 9
- Pages
- 430-430
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2789788398
- Cited by
- 323
- References
- 67
- FWCI
- 6.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.